Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route (2007)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; SOARES, IRENE DA SILVA - FCF
- Unidades: ICB; FCF
- DOI: 10.1590/s0074-02762007005000039
- Subjects: PLASMODIUM; VACINAS; ADJUVANTES IMUNOLÓGICOS
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2007
- Source:
- Título do periódico: Memórias do Instituto Oswaldo Cruz
- ISSN: 0074-0276
- Volume/Número/Paginação/Ano: v. 102, n. 3, p. 313-317, 2007
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
BARGIERI, Daniel Youssef et al. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, v. 102, n. 3, p. 313-317, 2007Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762007005000039. Acesso em: 18 abr. 2024. -
APA
Bargieri, D. Y., Rosa, D. S., Lasaro, M. A. S., Ferreira, L. C. de S., Soares, I. da S., & Rodrigues, M. M. (2007). Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route. Memórias do Instituto Oswaldo Cruz, 102( 3), 313-317. doi:10.1590/s0074-02762007005000039 -
NLM
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1590/s0074-02762007005000039 -
Vancouver
Bargieri DY, Rosa DS, Lasaro MAS, Ferreira LC de S, Soares I da S, Rodrigues MM. Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route [Internet]. Memórias do Instituto Oswaldo Cruz. 2007 ; 102( 3): 313-317.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1590/s0074-02762007005000039 - Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium
- Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3
- Analysis of immunogenicity of Plasmodium vivax merozoite surface protein 3 (MASP-3) in mice using different adjuvant formulations
- Malaria vaccine development: are bacterial flagellin fusion proteins the bridge between mouse and humans?
- Generation of plasmidial DNA encoding domain II of Plasmodium vivax apical membrane antigen 1 fused to Salmonella Typhimurium flagellin (FliC) to expression in Escherichia coli
- Geração de um plasmídeo recombinante baseado no domínio II do Antígeno 1 de Membrana Apical de Plasmodium vivax fusionado à flagelina FliC de Salmonella Typhimurium para expressão em Escherichia coli
- Expressão e purificação de uma proteína recombinante baseada no domínio II do antígeno 1 de membrana apical de Plasmodium vivax fusionada à flagelina (FliC) de Salmonella typhimurium
- New malaria vaccine candidates based on the Plasmodium vivax merozoite surface protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin
- The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate
- Interferon-G plays a critical role in CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins
Informações sobre o DOI: 10.1590/s0074-02762007005000039 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
